首页|期刊导航|时珍国医国药|基于PINK1/Parkin线粒体自噬通路探讨疏肝温胆汤抗动脉粥样硬化的分子机制

基于PINK1/Parkin线粒体自噬通路探讨疏肝温胆汤抗动脉粥样硬化的分子机制OA

Molecular mechanism of Shugan Wendan Decoction(疏肝温胆汤)against atherosclerosis via the PINK1/Parkin mitophagy pathway

中文摘要英文摘要

目的 探讨疏肝温胆汤通过PINK1/Parkin线粒体自噬通路对动脉粥样硬化的干预作用及分子机制.方法 将40只ApoE-/-小鼠随机分为正常对照组、模型组、疏肝温胆汤组和阿托伐他汀钙片组,各10只.治疗12周后,检测各组小鼠体质量、血脂谱(TC、TG、LDL-C、HDL-C)、炎症因子(TNF-α、IL-1β、IL-6、MCP-1)及氧化应激指标(SOD、MDA、GSH-Px);通过HE染色和透射电镜观察主动脉形态学变化和线粒体自噬状态;采用Western blot和RT-qPCR检测自噬相关蛋白(Beclin-1、PINK1、Parkin、P62、LC3II/LC3I)表达水平.结果 疏肝温胆汤组和阿托伐他汀组较模型组显著改善血脂谱紊乱(降低TC、TG、LDL-C,升高HDL-C),降低炎症因子水平(TNF-α、IL-1β、IL-6、MCP-1),增强抗氧化能力(提高SOD、GSH-Px,降低MDA),减轻主动脉内膜增厚和脂质沉积.两组均显著提高线粒体自噬能力,增加自噬体形成,改善线粒体结构,上调Beclin-1、PINK1、Parkin和LC3II/LC3I表达,下调P62表达(P<0.05),两治疗组效果相当.结论 疏肝温胆汤能显著改善动脉粥样硬化,其作用机制可能与激活PINK1/Parkin介导的线粒体自噬通路,降低炎症反应和氧化应激损伤有关.

Objective To investigate the interventional effect and molecular mechanism of Shugan Wendan Decoction(疏肝温胆汤,SGWDD)on atherosclerosis(AS)through the PINK1/Parkin-mediated mitophagy pathway.Methods Forty ApoE-/-mice were randomly divided into four groups(n=10 per group):normal control,model,SGWDD,and atorvastatin(positive control)groups.After 12 weeks of treatment,body weight,serum lipid profiles(total cholesterol/TC,triglycerides/TG,low-density lipoprotein cholesterol/LDL-C,high-density lipoprotein cholesterol/HDL-C),inflammatory cytokines(tumor necrosis factor-α/TNF-α,interleukin-1β/IL-1β,IL-6,monocyte chemoattractant protein-1/MCP-1),and oxidative stress markers(superoxide dismutase/SOD,malondialdehyde/MDA,gluta-thione peroxidase/GSH-Px)were measured.Aortic morphology and mitochondrial ultrastructure were evaluated by hematoxylin-eosin(HE)staining and transmission electron microscopy(TEM),respectively.The expression of autophagy-related proteins(Beclin-1,PINK1,Parkin,P62,LC3II/LC3I)was detected by Western blot(WB)and reverse transcription quantitative polymerase chain reaction(RT-qPCR).Results Compared with the model group,both the SGWDD and atorvastatin groups showed significant improvements:attenuated dyslipidemia(decreased TC,TG,and LDL-C;increased HDL-C),reduced levels of inflammatory cytokines(TNF-α,IL-1β,IL-6,MCP-1),enhanced antioxidant capacity(increased SOD and GSH-Px;decreased MDA),and ameliorated aortic intimal thickening and lipid deposition.Furthermore,both treatments significantly promoted mitophagy,as evidenced by increased autophago-some formation,improved mitochondrial structure,upregulated protein and mRNA expression of Beclin-1,PINK1,Parkin,and LC3II/LC3I,and downregulated expression of P62(all P<0.05).The effects of the two treatment groups were comparable.Conclusion SGWDD significantly ameliorates AS in ApoE-/-mice.The mechanism may be associated with the activation of the PINK1/Parkin-mediated mitophagy pathway,thereby reducing inflammatory response and oxidative stress.

蔡海荣;蔡惠铃;胡瑶;黄金悦;林敏如;陈伯钧;夏晓莉

广州中医药大学第二附属医院,广东 广州 510102广州中医药大学第二附属医院,广东 广州 510102广州中医药大学第二附属医院,广东 广州 510102广州中医药大学第二附属医院,广东 广州 510102广州中医药大学第二附属医院,广东 广州 510102广州中医药大学第二附属医院,广东 广州 510102广州中医药大学第二附属医院,广东 广州 510102

医药卫生

疏肝温胆汤动脉粥样硬化线粒体自噬PINK1/Parkin通路

Shugan Wendan Decoction(疏肝温胆汤)AtherosclerosisMitophagyPINK1/Parkin pathway

《时珍国医国药》 2026 (17)

3258-3264,7

国家自然科学基金面上项目(82074342)广州市科技计划项目(2024A04J3302)广东省中医药局科研项目(20233019,20251135,20264006)广东省中医院重点学科项目(01020245)

10.70976/j.1008-0805.SZGYGY-2026-1709

评论